SI1546182T1 - Sestavki in postopki za diagnozo in zdravljenje tumorja - Google Patents

Sestavki in postopki za diagnozo in zdravljenje tumorja

Info

Publication number
SI1546182T1
SI1546182T1 SI200331964T SI200331964T SI1546182T1 SI 1546182 T1 SI1546182 T1 SI 1546182T1 SI 200331964 T SI200331964 T SI 200331964T SI 200331964 T SI200331964 T SI 200331964T SI 1546182 T1 SI1546182 T1 SI 1546182T1
Authority
SI
Slovenia
Prior art keywords
compositions
tumor
diagnosis
treatment
methods
Prior art date
Application number
SI200331964T
Other languages
English (en)
Inventor
David P Davis
Frederic J Desauvage
William I Wood
Zemin Zhang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SI1546182T1 publication Critical patent/SI1546182T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
SI200331964T 2002-09-11 2003-09-05 Sestavki in postopki za diagnozo in zdravljenje tumorja SI1546182T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41016602P 2002-09-11 2002-09-11
EP03752035A EP1546182B1 (en) 2002-09-11 2003-09-05 Compositions and methods for the diagnosis and treatment of tumor
PCT/US2003/027886 WO2004024063A2 (en) 2002-09-11 2003-09-05 Compositions and methods for the diagnosis and treatment of tumor

Publications (1)

Publication Number Publication Date
SI1546182T1 true SI1546182T1 (sl) 2011-04-29

Family

ID=31994078

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331964T SI1546182T1 (sl) 2002-09-11 2003-09-05 Sestavki in postopki za diagnozo in zdravljenje tumorja

Country Status (10)

Country Link
US (3) US20040229232A1 (sl)
EP (2) EP1546182B1 (sl)
JP (4) JP2005537810A (sl)
AT (1) ATE494296T1 (sl)
AU (3) AU2003268494A1 (sl)
CA (2) CA2498004C (sl)
DE (1) DE60335636D1 (sl)
ES (2) ES2456696T3 (sl)
SI (1) SI1546182T1 (sl)
WO (2) WO2004024063A2 (sl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546182B1 (en) * 2002-09-11 2011-01-05 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2006034300A2 (en) * 2004-09-17 2006-03-30 Cornell Research Foundation, Inc. Great wall kinases and uses thereof
CN101223187A (zh) * 2004-11-24 2008-07-16 萨拉普托斯股份公司 用作双重胱天蛋白酶-2/-6抑制剂的新肽及其生物学应用
EP2395109A1 (en) * 2004-12-08 2011-12-14 Aventis Pharmaceuticals Inc. Method for measuring resistance or sensitivity to docetaxel
JP2008154573A (ja) * 2006-03-31 2008-07-10 Toyobo Co Ltd 可溶性グルコースデヒドロゲナーゼ（ｇｄｈ）を含む組成物の安定性を向上する方法
WO2007134245A2 (en) * 2006-05-12 2007-11-22 Wisconsin Alumni Research Foundation Elastin-like polymer delivery vehicles
HUE037173T2 (hu) 2006-08-08 2018-08-28 Univ Bonn Rheinische Friedrich Wilhelms 5'-Foszfát-oligonukleotidok szerkezete és alkalmazása
US20090011060A1 (en) * 2007-07-06 2009-01-08 Peter Koepke Campsiandra angustifolia extract and methods of extracting and using such extract
US7879369B2 (en) 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
AT506041A1 (de) * 2007-12-10 2009-05-15 Univ Innsbruck Verfahren zur erhöhung der immunreaktivität
US9738680B2 (en) 2008-05-21 2017-08-22 Rheinische Friedrich-Wilhelms-Universität Bonn 5′ triphosphate oligonucleotide with blunt end and uses thereof
EP2343294A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
EP2508530A1 (en) 2011-03-28 2012-10-10 Rheinische Friedrich-Wilhelms-Universität Bonn Purification of triphosphorylated oligonucleotides using capture tags
EP2712870A1 (en) 2012-09-27 2014-04-02 Rheinische Friedrich-Wilhelms-Universität Bonn Novel RIG-I ligands and methods for producing them
WO2014152831A2 (en) * 2013-03-14 2014-09-25 Health Research, Inc. Targeting peptides and uses thereof
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716575B2 (en) * 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
ES2255715T3 (es) * 1995-12-18 2006-07-01 Sugen, Inc. Diagnostico y tratamiento de transtornos relacionados con la aur-1 y/o la aur-2.
US5885803A (en) * 1997-06-19 1999-03-23 Incyte Pharmaceuticals, Inc. Disease associated protein kinases
WO1999065928A2 (en) * 1998-06-19 1999-12-23 Genzyme Corporation Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues
AU6181000A (en) * 1999-07-29 2001-02-19 Chugai Research Institute For Molecular Medicine, Inc. Novel genes encoding protein kinase/protein phosphatase
EP1240194A2 (en) * 1999-11-24 2002-09-18 Sugen, Inc. Novel human protein kinases and protein kinase-like enzymes
CA2410516A1 (en) * 2000-05-31 2001-12-06 Chiron Corporation Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
JP2004520806A (ja) * 2000-08-24 2004-07-15 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
WO2002016581A2 (en) * 2000-08-24 2002-02-28 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
AU8678501A (en) * 2000-08-24 2002-03-04 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor
CA2427858A1 (en) * 2000-11-03 2002-05-10 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
US20040029114A1 (en) * 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
EP1418943A1 (en) * 2001-02-14 2004-05-19 Protein Design Labs, Inc. Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
JP2005527180A (ja) * 2001-04-18 2005-09-15 プロテイン デザイン ラブス， インコーポレイテッド 肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法
US7125663B2 (en) * 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
CA2451465A1 (en) * 2001-06-18 2002-12-27 Eos Biotechnology Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
JP2005525789A (ja) * 2001-11-13 2005-09-02 プロテイン デザイン ラブス インコーポレイティド ガンの診断方法、ガンのモジュレータのスクリーニング組成物及び方法
WO2003042661A2 (en) * 2001-11-13 2003-05-22 Protein Design Labs, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
JP2005522999A (ja) * 2002-01-31 2005-08-04 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 癌を処置するための方法および組成物
EP1546182B1 (en) * 2002-09-11 2011-01-05 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor

Also Published As

Publication number Publication date
AU2010201526A1 (en) 2010-05-06
DE60335636D1 (de) 2011-02-17
JP2012046515A (ja) 2012-03-08
EP1546182A2 (en) 2005-06-29
JP2006517387A (ja) 2006-07-27
WO2004024064A2 (en) 2004-03-25
WO2004024063A2 (en) 2004-03-25
AU2003270348A1 (en) 2004-04-30
CA2498004C (en) 2013-06-11
ES2456696T3 (es) 2014-04-23
US20120045390A1 (en) 2012-02-23
AU2003268494A1 (en) 2004-04-30
JP2010131015A (ja) 2010-06-17
EP1546182B1 (en) 2011-01-05
EP1578760B1 (en) 2014-02-12
CA2498000A1 (en) 2004-03-25
ATE494296T1 (de) 2011-01-15
CA2498000C (en) 2015-01-20
CA2498004A1 (en) 2004-03-25
WO2004024063A3 (en) 2004-10-14
AU2003270348B2 (en) 2010-08-26
EP1546182A4 (en) 2006-09-06
EP1578760A2 (en) 2005-09-28
JP2005537810A (ja) 2005-12-15
ES2359055T3 (es) 2011-05-18
US20130210116A1 (en) 2013-08-15
US20040229232A1 (en) 2004-11-18
WO2004024064A8 (en) 2005-07-21
EP1578760A4 (en) 2007-07-11

Similar Documents

Publication Publication Date Title
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
MXPA05005107A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
MXPA03001645A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
ZA200702322B (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003088808A3 (en) Compositions and methods for the diagnosis and treatment of tumor
SG155947A1 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
EP2067472A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004112829A3 (en) Compositions and methods for the diagnosis and treatment of tumors of glial origin
MXPA05005223A (es) Diaminotriazoles utiles como inhibidores de proteinas cinasas.
MY150531A (en) Anti-cd79b antibodies and immunoconjugates and methods of use
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
WO2005049075A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
TW200612918A (en) Lonidamine analogs
EP1578760A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
WO2002016581A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
WO2005063299A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
WO2006014335A3 (en) Compositions and methods for treatment of non-hodgkin’s lymphoma
WO2004096124A3 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1590666A4 (en) COMPOSITIONS AND METHODS FOR REINFORCED APOPTOSIS
MXPA05008293A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
WO2006081272A3 (en) Compositions and methods for the diagnosis and treatment of tumor